Unlocking the Mysteries of Fragile X Syndrome: Exploring the Role of FMR1 Protein with ELISA Technology

The Human Fragile X Mental Retardation 1 protein (FMR1) ELISA kit is a laboratory tool designed for the quantitative measurement of FMR1 protein levels in biological samples. FMR1 is associated with Fragile X syndrome, a genetic disorder characterized by intellectual disability and behavioral challenges. The ELISA kit enables researchers and clinicians to accurately quantify FMR1 protein levels, aiding in the study of Fragile X syndrome and potentially contributing to diagnostic and therapeutic advancements in the field.



Storage Stability

Long-term stability of kit components, particularly reagents and plates, allows for convenient storage and ensures consistent performance over time, minimizing the need for frequent kit replacements.



Consistent and reproducible results are crucial for reliable data interpretation. The kit should demonstrate high levels of reproducibility between assays and across different users or laboratories.

Wide Dynamic Range

A broad dynamic range accommodates varying concentrations of FMR1 protein in different samples, allowing for accurate quantification across a wide range of concentrations without the need for sample dilution.



Diagnostic Screening

The ELISA kit can be used for screening and diagnosis of Fragile X syndrome, a genetic disorder caused by mutations in the FMR1 gene. Measurement of FMR1 protein levels in patient samples can aid in the identification of individuals affected by Fragile X syndrome.

Research Studies

Researchers utilize the ELISA kit to investigate the role of FMR1 protein in normal physiological processes and its dysregulation in Fragile X syndrome. This includes studying its expression levels in various tissues, developmental stages, and disease conditions.

Genetic Counseling

Quantification of FMR1 protein levels in individuals with Fragile X syndrome can provide additional information for genetic counseling, aiding in family planning decisions and providing insights into disease severity and prognosis.

Your Dynamic Snippet will be displayed here... This message is displayed because you did not provided both a filter and a template to use.
Catalyst for Discovery: Harnessing the Potential of Human Epiregulin (EREG) with ELISA Technology"